Pharma Patent Trials Loom in 2026 for Wegovy, Covid-Vaccine Tech

Patent lawsuits involving some of the pharmaceutical industry’s most buzzworthy drugs and technologies—including the blockbuster weight-loss drug Wegovy and the delivery technology behind Covid-19 vaccines—are set to go to trial in 2026.

Here are a few of the biggest trials for practitioners to follow in the new year:

GLP-1 Drugs

Novo Nordisk Inc.’s suit seeking to block copies of Wegovy proposed by Viatris Inc.’s Mylan unit has a bench trial scheduled to start March 2 in the US District Court for the District of Delaware.

Among the first patent suits over a GLP-1 weight-loss treatment to reach trial, this case ...